Tweet  Since the publication of our March 30, 2011 article on melanoma on this blog, interest in melanoma has remained high. This is to be expected, with the March 2011 approval of ipilimumab (Medarex/Bristol-Myers Squibb’s Yervoy), and the expected approval of Daichi Sankyo/Plexxikon/Roche’s PLX4032/RG7204 in the near future. The April 2011 issue of the Faculty…